We aimed to identify by computed tomography (CT) the best suited of three anthropometric indices that reflect the visceral adipose tissue (VAT), and to discern the relationship between VAT and certain atherogenic risk factors and coronary heart disease (CHD) diagnosis in a population sample which had a high (34%) prevalence of the metabolic syndrome (MS). METHODS: A single-scan CT was performed between the fourth and fifth lumbar vertebrae in 157 unselected men and women aged 34-69 y. Total adipose tissue area, abdominal VAT area and the abdominal sagittal diameter were determined. Diagnosis of CHD was based on clinical findings and Minnesota coding of resting electrocardiograms. RESULTS: Men had significantly higher VAT than women. Linear regression analysis for correlates of abdominal VAT area, in a model comprising age, sex, waist circumference, waist-to-hip ratio (WHR) and body mass index (BMI) identified waist circumference as the only independent variable (Po0.001). Waist circumference in men and BMI in women were the independently associated parameters of sagittal diameter (Po0.001). By stepwise linear regression, it was elicited that VAT area rose significantly by a mean of 6.8 cm 2 in men and 3 cm 2 in women for every 1 cm increment in waist circumference, independent of WHR. Age in women and (inversely) BMI in men were further independent variables, indicating in men that a lower BMI at a given waist girth suggests the existence of a higher VAT. Apo B and HDL-cholesterol (HDL-C) in men, and the latter in women were independently associated with VAT area in linear regression models that also comprised triglycerides, fasting insulin and C-reactive protein concentrations. In the study sample comprising 13 individuals with a CHD diagnosis, the age-adjusted odds ratio of cutpoints of VAT area 4 vs o140 cm 2 in men and 4 vs o120 cm 2 in women was 11.3 (95% CI (1.37, 93)). CONCLUSIONS: The best surrogate of visceral adiposity across a wide age range is waist circumference, in a population in which MS prevails. Apo B and HDL-C in men, and the latter in women were independently associated with VAT area, which proved to be closely related to CHD risk. A lower BMI at a given waist girth in men suggests the existence of a higher VAT.
Introduction
Since body mass index (BMI) has only a fair correlation with more direct measures of body fatness 1 and a limited ability to reflect adiposity, that is, body fat distribution 2 to which cardiovascular risk is more related, abdominal obesity (central adiposity) has recently been considered to be more important in the evaluation of coronary heart disease (CHD) risk, as the epidemiological link was shown in the Göteborg study. 3 Other more recent studies provided further evidence that abdominal obesity is a more important risk factor for CHD than overall obesity, [4] [5] [6] and that the risk associated with abdominal obesity starts to increase at the lower end of the population-specific distribution. 5, 6 Initially waist-to-hip ratio (WHR) and later also waist circumference 7 were used as measures of abdominal obesity. Intra-abdominal fat volumes in obese Afro-American women differ from those of WHR-matched Caucasians. 8 The more cardioprotective plasma lipoprotein profile found in abdominally obese black vs white persons was partly explained by a lower visceral AT accumulation and a higher plasma lipoprotein lipase activity in black individuals. 9 Hence, as also shown in the WHO MONICA study, the issue of the sensitivity and specificity of detecting abdominal obesity may be populationspecific. 10 So, the need is apparent for continuing assessment of these anthropometric indices in different populations until the question of optimal measure is resolved.
We therefore aimed in this study: (a) to identify by computed tomography (CT) the best suited of three anthropometric indices to reflect visceral adipose tissue (VAT); (b) to discern the relationship between VAT and certain atherogenic risk factors on the one hand and (c) CHD diagnosis on the other, and (d) to possibly obtain threshold values of such an index for coronary disease risk in adults with a high prevalence of the metabolic syndrome (MS). 11 
Methods

Subjects
Included subjects consisted of residents of the city of Istanbul within the cohort of the Turkish Adult Risk Factor Study, 12 who also had available data on lipid and nonlipid parameters. In all, 78 men and 79 women were recruited. Subjects were given a written informed consent document before entering the study. Consent was obtained in all those enrolled. Inclusion criteria furthermore stipulated an age range between 34 and 69 y and residence in Istanbul, for economical and logistic reasons. Approximately 80 men and 80 women were targeted. Out of a total of 265 eligible individuals, no further selection was made, but unwillingness to participate, failure to show up for the appointment and the inability to contact a small part of the cohort, reduced the number of examinees to the targeted 157 men and women. Just over half (42 of 79) of the women were postmenopausal. In the remainder, examinations were obtained between the fifth and the 12th days of their menstrual cycle. Cardiovascular examination and anthropometric measurements were performed by a cardiologist (GSA) before the tomographic examination.
Measurement of anthropometry and total body fatness
The person was weighed with a scale barefoot and without heavy clothing, to within 0.2 kg; the height was measured to within 0.5 cm. Waist circumference was measured using a spring scale (O Haus, Florham Park, NJ, USA), with the subject standing and wearing only underwear, at the end of gentle expiration at the level midway between the lower rib margin and the iliac crest, while that of the hip was measured at the level of the great trochanters. BMI was calculated by the computer as weight divided by height squared (kg/m 2 ). Body composition was measured by the hydrostatic weighing technique with a body composition analyzer (Tanita TBF 300, Japan). An average of two measurements was used to estimate the percent body fat, from which body fat mass was computed with the value of body weight.
CT was performed on a Siemens Somatom AR SP 40 (Erlangen, Germany) spiral scanner according to Sjöström et al's 13 procedure and described by Ferland et al.
14 Tomographic examinations were carried out in the supine position with both arms stretched above the head. A single axial scan was made at the abdominal level, between the fourth and fifth lumbar vertebrae, using an abdominal topogram. The sagittal diameter of the abdomen was determined from the abdominal image generated by the computer by connecting the anterior and posterior midline points. Total adipose tissue areas were calculated by delineating the abdomen with a graph pen and then computing the adipose tissue surface using an attenuation range of -1901 to À301 Hounsfield units. 13 Within the muscle wall around the abdominal cavity, a line was drawn to measure the abdominal VAT area. By subtracting the abdominal VAT area from the total adipose tissue area, the abdominal subcutaneous area was obtained.
Measurement of other risk factors
Blood pressure was measured in the sitting position on the right arm using an aneroid sphygmomanometer (Erka, Germany), after at least 5 min of rest. The first appearance and disappearance (phase V) of Korotkoff sounds were used to define the pressures. Readings were recorded to the nearest even number, and the mean of two recordings 3 min apart was computed. Plasma concentrations of cholesterol, HDL-cholesterol (HDL-C), fasting triglycerides and glucose were determined by the enzymatic dry chemistry method using a Reflotron apparatus (Roche Diagnostics, Mannheim, Germany). Glucose was sampled in the postabsorptive state (in 82%), and 2 h postprandially (in 18%) of participants. Individuals with diabetes mellitus or glucose intolerance were identified by self-report or by adhering to the criteria of the World Health Organization. Plasma concentrations of C-reactive protein (CRP) were measured by means of particle-enhanced immunonephelometry with the Behring nephelometer method, using N Latex CRP mono reagent (Behring Diagnostics, Westwood, MA, USA). 15 Plasma apolipoprotein B levels were measured by the immunoturbidimetric method (Turbitimer, Behring Diagnostics). Concentrations of insulin were determined by the chemiluminescent immunometric method using Diagnostic Products Corporation kits and the autoimmunanalyzer Immulite (Los Angeles, CA, USA). The mean values for serum concentrations of insulin and CRP are geometric means calculated from the log-transformed distribution. External quality control was performed with a reference laboratory in a random selection of 5-6% of participants. Collected survey data were checked by the primary investigator before and after being included in the database with the purpose of assuring data quality and completeness. Diagnosis of CHD was based on the presence of typical exertional angina pectoris, of a history of myocardial infarction with or without accompanying Minnesota codes of the ECG, 16 or on a history of myocardial revascularization.
Among women, even typical angina before age 45 precluded the diagnosis.
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Data analysis
Data are presented as mean values7s.d. Partial correlations, controlled for age, were computed between variables. T-tests were used to analyse differences between groups, whereby Levene's test for equality of variances was considered. The independent associations between risk variables were tested in linear regression models, using stepwise regression. Independent associations between risk variables and CHD diagnosis were evaluated by logistic regression. Regression models were adjusted for confounding variables (age, sex, etc). Curves were designed to elicit optimal cutoff points of VAT for CHD, separately in men and women. Due to the skewed distribution of CRP and fasting insulin values, these parameters were log-transformed for calculations. A value of Po0.05 was considered statistically significant. Calculations were carried out on a PC using SPSS for Windows (Version 7.5).
Results
Characteristics of the subjects given in Table 1 indicate that a wide range of measures of obesity and abdominal obesity is comprised within the study sample. These values are representative of middle-aged Turkish adults except for having a somewhat higher prevalence of hypertension and dyslipidemia and, in women, a smaller proportion of abdominal (but not overall) obesity. MS, being observed in 25 men and 28 women, prevailed in one-third of the sample.
Tomographic measures of abdominal adiposity
The mean abdominal VAT areas in men and women were 144.5760 and 120.5758 cm 2 , respectively (P ¼ 0.012), and the mean abdominal subcutaneous areas 227796 and 3367107 cm 2 pointing to a relative preponderance of visceral AT than subcutaneous AT in both genders (Table 2) . Among subjects with MS, the mean sagittal diameter was insignificantly greater by 11%, and VAT area by 42% (Po0.001) than in individuals without MS. Visceral AT rose with age (Po0.04 in men, o0.001 in women). Pearson correlation coefficients between anthropometric measures and abdominal adipose tissue variables, by gender, are presented in Table 3 . After controlling for age, correlations were high and tended to be higher in men than in women: VAT area was best correlated with sagittal diameter (r ¼ 0.83 in men and 0.73 in women) and with waist circumference (r ¼ 0.82 in men and 0.67 in women). Although correlations were both very significant and high, abdominal VAT area was not very satisfactorily reflected by WHR (r ¼ 0.47 and 0.34 in men and women). Men exhibited on average a 9% higher VAT area than women for a given waist circumference (1.52 vs 1.40; P ¼ 0.15), and a clearly Table 1 Values of anthropometric indices and cardiovascular risk factors, by gender and presence of metabolic syndrome Visceral adiposity and relation to coronary risk A Onat et al higher VAT area than women for a given body fat mass (6.56 vs 4.6; P ¼ 0.001).
The abdominal sagittal diameter showed uniformly high correlations with either the visceral or the subcutaneous AT area in men, but slightly less high with VAT in women. The sagittal diameter was also highly correlated with waist circumference and BMI in both genders (Table 3) . Body fat mass, controlled for age, was best reflected by BMI (r ¼ 0.90, 0.93 in men and women, respectively), but also by waist girth (r ¼ 0.87, 0.88 in men and women, respectively). By contrast, WHR was only modestly correlated with fat mass (0.04 and 0.23 in men and women, respectively). Table 4 shows that, in a stepwise linear regression model including sex, age and the three anthropometric indices, waist circumference was the best independent correlate of VAT area in the entire study sample, followed by age in women, andFinverselyFby BMI in men. In a 50-y-old woman, waist girths of 80 and 88 cm would be associated with mean VAT areas of 109 and 133 cm 2 , respectively, while each decade would add on average 17 cm 2 of VAT. Men, who seem more prone than women to a sharp rise in VAT with waist girth, appear to develop a slightly greater VAT at a lower BMI than a higher one (Figure 1) . A similar regression analysis identified waist circumference as the only significant independent parameter of abdominal sagittal diameter in men, whereas BMI was so in women (Table 4) .
Best marker of visceral adiposity
Relationship between visceral adiposity and metabolic risk variables VAT area and abdominal sagittal diameter as dependent variables were analysed in stepwise regression models for independent associations with metabolic (apo B, triglycerides, total and HDL-C) and proinflammatory variables (CRP), as well as sex and age (Table 5 ). These models comprised 68 men and women with no missing values. Apo B and HDL-C were the only independent parameters associated with VAT in men, whereas in women HDL-C was the sole significant independent variable. The regression equation indicated that an excess of 20 cm 2 of VAT area was associated with a decline of HDL-C by 9 mg/dl in men and 6 mg/dl among women. A similar increment in VAT in men was involved with a rise of 27 mg/dl in apo B. A threshold of 140 cm 2 of VAT corresponded to levels of 120 mg/dl of apo B, accompanied by 34 mg/dl of HDL-C, each recognized as critical for CHD risk, and this threshold is reflected by a waist girth of 94 cm at a BMI of 28 kg/m 2 .
With regard to the sagittal diameter, log fasting insulin was the main correlate in both genders; the balance between the principal correlate apo B and total cholesterol were selected as the cutoff for abnormality in Turkish men and women, respectively. By the use of these cutpoints and taking both genders combined, whereas 12 out of 71 individuals (17%) with a larger area had CHD, one of 86 subjects (1.2%) with a smaller area had this diagnosis, exhibiting a very high sensitivity (99%) and a good specificity (58%). The age-adjusted odds ratio for prevalent CHD risk in a logistic regression analysis proved to be a significant 11.3 (95% CI (1.37, 93)), which doubled for every 50 cm 2 rise in VAT area. The age-adjusted odds ratio of the abdominal sagittal diameter was also significant (P ¼ 0.013), namely, 1.29 (95% CI (1.06, 1.58)) for each cm increment in diameter.
Discussion
The present study examined the associations between anthropometric indices as well as metabolic risk factors and visceral adiposity, as assessed by CT in unselected middle-aged Turkish men and women. The cutpoints of VAT area for high CHD risk and the best anthropometric index as surrogate of VAT were sought in a study sample in whom abdominal obesity is highly prevalent, a feature which is even more common in the general female population than in the studied sample.
Susceptibility to accumulate visceral adiposity
Compared to the Canadian sample, 17 both genders had higher values of VAT area per unit of waist circumference (men 1.52 vs 1.27 and women 1.40 vs 1.20), per unit of body fat mass (men 6.4 vs 5.5 and women 4.5 vs 3.1) and a higher VAT (men 40 vs 33% and women 26% vs 20%) in proportion of total abdominal AT area. The susceptibility to develop visceral adiposity in this population sample is also reflected by the observation that VAT area rose significantly by a mean of 6.9 cm 2 in men and 3 cm 2 in women for every 1 cm increment in waist circumference, independent of age, BMI and WHR. Men had significantly higher VAT than women, in congruence with the well-known divergence between sexes in regional adipose tissue distribution. 18 This was at mild variance with the findings of Pouliot et al, 17 who found men and women to have similar values for VAT of a given waist circumference. The model comprised also age, total cholesterol, HDLcholesterol, triglycerides and log C-reactive protein in 68 persons.
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Best index of visceral adiposity
Waist circumference proved to be the best-suited anthropometric index to reflect central adiposity (VAT area) determined by computed tomography. This parameter confirms the previous experience on a Western population, 17 though waist in Turkish women was observed to be a somewhat weaker correlate of central adiposity (r ¼ 0.69 compared to 0.87). WHR ratio did not contribute further to the association with VAT and BMI not in women.
To our knowledge, we are the first to report that in men, at a given waist girth, BMI is inversely associated with VAT. Women did not exhibit this feature, which points to a commensurate overall obesity and visceral adiposity in them, while men displayed a selective accumulation of visceral adiposity, to some extent discordant with obesity per se. Existence of a higher BMI at a given waist girth depends largely on a preferential accumulation of subcutaneous fat tissue; and peripheral fat mass was recently shown in elderly women to exhibit an antiatherogenic effect. 19 By studying the acute insulin response in over 1450 Hispanic and African-American adults in the IRAS study, Wagenknecht et al 20 newly documented that abdominal visceral/subcutaneous fat distribution is an important determinant of both insulin sensitivity and insulin secretion. The insulin-sensitizing and antiatherogenic properties of peripheral fat mass is mediated by adiponectin secreted in adipocytes; 21 by contrast, men with abdominal obesity without a marked overall obesity are at greater risk. This knowledge provides practical value in identifying subjects at high cardiovascular risk and in not feeling lax in abdominally obese men who fail to meet the criterion of overall obesity. Waist circumference is believed to be determined by the extent of abdominal obesity, which is linked to visceral adiposity. WHR, a recognized good index, 22 was found not to contribute independently to visceral adiposity (VAT) in this sample, and its correlations with sagittal diameter and body fat mass were also modest. Lack of significant correlation was reported in Mexican-American women between WHR and abdominal AT volume. 23 BMI and WC were excellent correlates of body fat mass in women of this study (r ¼ 0.93 and 0.87). In men, waist girth was more strongly associated with VAT area than in women. This is in keeping with the findings of Seidell et al, 7 who reported that waist added 8% in men to the variance of abdominal VAT area explained by age and BMI, but none in women.
Thresholds of high risk for metabolic complications and for CHD Critical for reliability as a measure of visceral adiposity is its relationship to dyslipidaemia, insulin resistance and markers of inflammation. In linear regression analyses in which age, fasting insulin, triglycerides, HDL-C, total cholesterol, apo B and CRP were included, HDL-C in women, and HDL-C together with apo B in men were the sole variables significantly and independently associated with VAT. The magnitude of the association was such that a decline of HDL-C by 9 mg/dl among men and 6 mg/dl in women was associated with an excess of 20 cm 2 of VAT area. In men apo B was the principal factor associated with VAT. Correlations between dyslipidemia and VAT area were first described by Pouliot et al, 17 , Turkish women would be expected to display mean HDL-C concentrations of 50.1 and 32.5 mg/dl, respectively. We have, furthermore, documented in Turkish men that the dyslipidemia (specifically HDL-C level) is not only a function of VAT area but also depends on the existing apo B concentrations: at a given HDL value, the higher the apo B, the higher the anticipated VAT area.
Our analysis suggests that shorter sagittal diameters and a waist circumference of Z94 cm in men and 484 cm in women are likely to be associated with visceral adiposity, insulin resistance and a related dyslipidemia. The abdominal sagittal diameter proved to be chiefly related to fasting insulin concentrations, whereby doubling of insulin values would be expected to be associated with two-thirds of the standard deviation of the sagittal diameter. In men, a ratio of apo B/total cholesterol Z0.7 would tend to enlarge the sagittal diameter, being in line with the notion that visceral obesity is associated with elevated small dense LDL rather than large LDL particles.
Plasma HDL-CFbut not apo A-IFconcentrations were significantly associated with both an elevated VAT and by levels of triglycerides, apo B, and insulin in 111 young men, 25 suggesting that levels of HDL-C are more closely associated with features of the visceral obesity-insulin resistance syndrome than plasma apo A-I. In the development of the metabolic syndrome, evidence was found in the prospective San Antonio Heart Study comprising nearly 2000 non-Hispanic whites and Mexican American men and women that waist circumference and BMI remained significant predictors of metabolic syndrome. 26 Adjustment for baseline levels of fasting insulin had only a small effect on the ability of these indices to predict the metabolic syndrome. Though our observation regarding the significant direct association between VAT area and CHD is limited by the relative paucity of cases with CHD, by the cross-sectional nature of the study and by not being angiographically verified in most cases, its meaning should not be underVisceral adiposity and relation to coronary risk A Onat et al toned, because it does illustrateFfor the first timeFthe direct link between VAT area and CHD likelihood. Prior work had established the role of anthropometric measures of abdominal obesity in the development of CHD. [4] [5] [6] Individuals in the present study having a greater VAT area than a cutpoint demonstrated a 11-fold greater age-adjusted CHD likelihood than the remainder. Based on an analysis of optimal likelihood for prevalent CHD in our data, we have selected areas of 4140 and 4120 cm 2 for men and women, respectively, which is also in keeping with the moderately higher visceral adiposity in Turkish men than women for a given waist circumference. In a study sample comprising 403 men and women, an abdominal VAT area of 4130 cm 2 had been considered to be a critical area in both genders, reflected by a waist circumference 495 cm. 27 On the other hand, a cutoff of 118 cm 2 of VAT was regarded as high among 98 postmenopausal Mexican women (which corresponded to a waist circumference of 84 cm), based on a less favorable metabolic profile comprising insulin, triglycerides, apo B and HDL-C values. 28 The threshold of 94 cm of waist circumference in men to reflect visceral adiposity is in keeping with the information as to the most appropriate cutpoint of waist circumference to be used in the prediction of CHD events in a population inclined to insulin resistance, obtained in the entire cohort of the Turkish Adult Risk Factor study in a recent analysis of 2350 men and women. In that study, Z96 cm appeared the best threshold in men, which was associated with significantly elevated levels of selected cutpoints of apolipoprotein B, CRP, fasting insulin, and with the prevalence of diabetes mellitus. 29 Such a threshold is in agreement with findings in
Finnish men for whom a waist of Z96 cm represented the highest quartile and the highest CHD risk, adjusted for some risk factors. 21 It is also in line with the statement in a footnote of the NCEP ATPIII guideline 30 to the effect that some men can develop multiple metabolic risk factors when waist circumference is increased to only 94-102 cm, as well as with the waist threshold of 95 cm in both sexes corresponding to critical amounts of VAT. 27 The deterioration in the lipoprotein-lipid profile observed in women with impaired glucose tolerance was shown by Pascot et al 31 to be largely related to the increased visceral AT depot found in obese women, and only partly (in particular plasma triglyceride levels) related to change in glucoseinsulin homeostasis. It is currently unclear whether the decline in VAT below a given threshold significantly improves the metabolic profile. The recent study by Brochu et al 32 in 25 sedentary obese postmenopausal women suggested that a major decrease in VAT (from a mean of 223 to 96 cm 2 ) through weight loss appeared to yield similar metabolic improvements as a moderate diminution to 171 cm 2 . Yet, the small sample size precludes a firm judgement in this regard.
We conclude that waist circumference is clearly the best surrogate of measures of visceral adiposity assessed by CT. A lower BMI at a given waist girth in men suggests the existence of a higher VAT. Measures of visceral adiposity are closely related to hyperinsulinemia and to abnormalities in HDL-C and apo B, as well as to CHD risk. VAT areas of 4140 cm 2 in men and 4120 cm 2 in women are proposed cutpoints for high-risk visceral adiposity among Turkish adults.
